Home
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Tag: Patents
Never say never – Why the High Income Countries that opted-out...
Christopher Garrison
-
April 8, 2020
Covid-19 and the comeback of compulsory licensing
Ellen 't Hoen
-
March 23, 2020
The Expanding Reach of the European Patent Office. Good for Health?
Ellen 't Hoen
-
March 18, 2020
Uganda tells ARIPO: No more patents for pharmaceuticals
Ellen 't Hoen
-
October 8, 2019
Corbyn’s Compulsory Licenses. Will they work?
Ellen 't Hoen
-
September 26, 2019
Strong call for transparency on medicine prices, cost of R&D at...
Ellen 't Hoen
-
April 19, 2019
Faced with unreasonable medicines prices, the Netherlands introduces pharmacy exemption in...
Ellen 't Hoen
-
February 22, 2019
New Database Documents the Power of TRIPS Flexibilities
Ellen 't Hoen
-
November 27, 2018
Dutch health insurance company Menzis takes AstraZeneca to court over patent...
Ellen 't Hoen
-
September 20, 2018
How patents, data exclusivity and SPCs interact to extend market exclusivity...
Pascale Boulet
-
July 10, 2018
1
2
Page 1 of 2
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
Ok
This work is licensed under Creative Commons.